Tag: Opioids
2016 to 2022 Saw Initiation Rate of Buprenorphine Increase, Stabilize
Median monthly retention rate was 22.2 percent during January 2016 through April 2022
Maker of Narcan Nasal Spray Plans to Sell Overdose Antidote for Less Than $50
The U.S. Food and Drug Administration approved OTC Narcan nasal spray last month to be sold without a prescription
Fibromyalgia Is Risk Factor for Opioid Use Disorder Exacerbations
New instrument, the Pain-related OUD Exacerbation Scale, shows validity
Placebo + Methadone Improves Opioid Use Disorder Treatment Retention
Conditioned open-label placebo had no impact on the 90-day methadone dose, but did improve sleep quality
2012 to 2019 Saw Rise in Naloxone Rx in the Emergency Department
Increases also seen for coprescribing with opioids
Buprenorphine Cuts Risk for Death After Nonfatal, Opioid-Involved Overdose
However, fewer than one in 20 individuals receive buprenorphine
Suicide Deaths Positively Linked to Measures of Opioid Prescribing
Significant associations seen for suicide deaths with opioid prescriptions per capita, having any, high-dose, long-term opioid prescription
Emergency Department-Administered Buprenorphine Is Safe, Effective
Rates of precipitated withdrawal are less than 1 percent
Postpartum Opioid Fills Increased With Onset of Pandemic
Observed increases were larger for patients who delivered by C-section than for those with vaginal delivery
Recreational Cannabis Tied to Unintended Harms, Benefits
Car crash fatalities up in these states, but opioid overdose deaths down
